Skip to main content
. 2015 Jun 24;15:586. doi: 10.1186/s12889-015-1875-2

Table 1.

Facility and client-level characteristics of abortion clients (n = 29,056)

Variable N (%)
Facility-level characteristics
Women served by facility-level
Hospital 23,261 (80.1)
Health center 4,141 (14.3)
Maternity home 1,654 (5.7)
Women seen by type of provider
House Officer 2,799 (9.6)
Physician 13,753 (47.3)
Midwife 12,504 (43.0)
Women served by facility region
Ashanti 6,476 (22.3)
Eastern 8,777 (30.2)
Greater Accra 13,803 (47.5)
Client-level characteristics
Client age (years)
10-19 4,400 (15.4)
20-29 15,321 (52.7)
30-39 7,451 (25.6)
40-49 1,117 (3.8)
Missing 767 (2.6)
Mean client age (SD), years 26 (6.7)
Trimester
1st Trimester 24,077 (82.9)
2nd Trimester 2,509 (8.6)
Missing 2,470 (8.5)
Mean gestational age (SD), weeks 8.6 4.2
Uterine evacuation procedure type
MVA or EVA 27,870 (95.9)
Medical abortiona 1,083 (3.7)
D&C or D&E 103 (0.4)
Indication for abortion
Postabortion care 17,019 (58.6)
Induced abortion 12,037 (41.4)
Postabortion contraception received
Short-acting methodb 14,521 (50.0)
Long-acting and permanent methodc 4,240 (14.6)
No method 10,295 (35.4)
Type of postabortion contraception
Male condom 2,680 (9.2)
Female condom 668 (2.3)
Oral contraceptives 4,550 (15.7)
Injection 6,553 (22.6)
Spermicide/Emergency contraception 70 (0.2)
IUD 1,347 (4.6)
Contraceptive implant 2,799 (9.6)
Bilateral tubal ligation 94 (0.3)
No method 10,295 (35.4)

MVA, manual vacuum aspiration; EVA, electric vacuum aspiration; D&C, dilation & curettage; D&E, dilation & extraction; IUD, intra-uterine device

aMedical abortion refers to treatment with either misoprostol or a combination misoprostol and mifepristone

bShort-acting contraceptive method refers to: barrier methods, oral contraception, injectables, spermicide, emergency contraception

cLong-acting and permanent contraceptive method refers to: IUD, contraceptive implant, bilateral tubal ligation